We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.06%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$75.4B
AUM Growth
-$3.33B
(-4.2%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
1,814
New
77
Increased
635
Reduced
934
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$241M |
| 2 |
Kraft Heinz
KHC
|
+$207M |
| 3 |
Apple
AAPL
|
+$196M |
| 4 |
Targa Resources
TRGP
|
+$152M |
| 5 |
Progressive
PGR
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$573M |
| 2 |
ICICI Bank
IBN
|
+$231M |
| 3 |
Mercado Libre
MELI
|
+$210M |
| 4 |
Visa
V
|
+$206M |
| 5 |
JPMorgan Chase
JPM
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.14% |
| 2 | Consumer Discretionary | 13.35% |
| 3 | Energy | 12.59% |
| 4 | Healthcare | 11.74% |
| 5 | Communication Services | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QGENF
526
DELISTED
QIAGEN NV
QGENF
| $21.9M | 0.03% |
982,575
-520
| -0.1% | -$11.6K |
|
527
Boise Cascade
BCC
$2.74B
| $21.9M | 0.03% |
1,055,075
+265,121
| +34% | +$5M |
|
|
HW
528
DELISTED
Headwaters Inc
HW
| $21.8M | 0.03% |
1,099,420
+51,903
| +5% | +$870K |
|
529
Eldorado Gold
EGO
$8.31B
| $21.8M | 0.03% |
1,380,168
+26,769
| +2% | +$387K |
|
530
Corning
GLW
$126B
| $21.7M | 0.03% |
1,041,174
-3,422
| -0.3% | -$63.4K |
|
|
P
531
DELISTED
Pandora Media Inc
P
| $21.7M | 0.03% |
2,422,119
+510,439
| +27% | +$5.01M |
|
|
EXAS
532
DELISTED
Exact Sciences
EXAS
| $21.7M | 0.03% |
3,213,370
+435,940
| +16% | +$2.79M |
|
533
Papa John's
PZZA
$999M
| $21.6M | 0.03% |
398,254
-159,094
| -29% | -$8.36M |
|
|
RHT
534
DELISTED
Red Hat Inc
RHT
| $21.5M | 0.03% |
288,990
+39,245
| +16% | +$2.77M |
|
535
Avnet
AVT
$7.33B
| $21.5M | 0.03% |
485,472
-16,302
| -3% | -$670K |
|
536
Inogen
INGN
$167M
| $21.4M | 0.03% |
476,490
+20,073
| +4% | +$715K |
|
537
Agilent Technologies
A
$39.1B
| $21.4M | 0.03% |
536,839
+89,590
| +20% | +$3.41M |
|
538
TripAdvisor
TRIP
$1.59B
| $21.2M | 0.03% |
318,975
-856,492
| -73% | -$56.7M |
|
|
AMID
539
DELISTED
American Midstream Partners, LP
AMID
| $21.2M | 0.03% |
3,060,759
+4,855
| +0.2% | +$31.7K |
|
540
T. Rowe Price
TROW
$25B
| $21.1M | 0.03% |
286,624
+6,950
| +2% | +$483K |
|
541
Abbott
ABT
$180B
| $21M | 0.03% |
502,766
-178,128
| -26% | -$7.06M |
|
|
MRO
542
DELISTED
Marathon Oil Corporation
MRO
| $21M | 0.03% |
1,883,979
+728,455
| +63% | +$6.81M |
|
543
MGIC Investment
MTG
$6.27B
| $20.9M | 0.03% |
2,731,225
+175,900
| +7% | +$1.26M |
|
544
Beazer Homes USA
BZH
$907M
| $20.9M | 0.03% |
2,398,685
-6,310
| -0.3% | -$52.5K |
|
545
Ultragenyx Pharmaceutical
RARE
$2.65B
| $20.9M | 0.03% |
329,800
+18,851
| +6% | +$1.23M |
|
546
HCA Healthcare
HCA
$84.8B
| $20.9M | 0.03% |
267,350
-16,253
| -6% | -$1.13M |
|
547
Criteo
CRTO
$1.03B
| $20.7M | 0.03% |
500,000
| – | – |
|
548
Theravance Biopharma
TBPH
$874M
| $20.7M | 0.03% |
1,100,845
-2,640
| -0.2% | -$43.2K |
|
|
WPX
549
DELISTED
WPX Energy, Inc.
WPX
| $20.7M | 0.03% |
2,959,984
+243,834
| +9% | +$1.24M |
|
550
Neurocrine Biosciences
NBIX
$17.7B
| $20.7M | 0.03% |
522,560
+222,222
| +74% | +$8.82M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2016 Portfolio in Review
As of Q1 2016, OppenheimerFunds held 1,814 positions worth $75.4B, down 4.2% from $78.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q1 2016 filing shows 77 new, 635 increased, 934 reduced and 133 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,497,249 shares worth $122M. The largest sale was Gilead Sciences, an estimated $573M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q1 2016 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,497,249 shares worth $122M.
- OppenheimerFunds added most to McDonald's in Q1 2016, an estimated $241M increase.
- OppenheimerFunds's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $573M.
- OppenheimerFunds fully exited Mercado Libre in Q1 2016, selling an estimated $210M.
- OppenheimerFunds's ten largest holdings make up 14% of its $75.4B portfolio in Q1 2016.
- OppenheimerFunds opened 77 new positions and closed 133 in Q1 2016.
- OppenheimerFunds's portfolio value fell 4.2% quarter-over-quarter to $75.4B.
Based on OppenheimerFunds's 13F filing for Q1 2016, filed 12 May 2016.